1Marks LB, Munley MT, Bentel GC et al. Physical and biologi- cal predictors of changes in whole-lung function following tho- racic irradiation[J]. Int J Radiat Oncol Biol Phys, 1997,39:563- 570.
2Gopal R, Tucker SL, Komaki R, et al. The relationship be- tween local dose and loss of function for irradiated lung[J]. Int Radiat Oncol Biol Phys, 2003,56 : 106-113.
3Yorke ED, Jackson A, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radia- tion therapy[J]. Int J Radiat Oncol Biol Phys, 2002,54: 329- 339.
4WillnerJ, JostA, BaierK, etal. Alittletoalot oralot to a little? An analysis of pneumonitis risk from dose-volume histo- gram parameters of the lung in patients with lung cancer treated with 3D comformal radiotherapy[J]. Strahlenther Onkol, 2003, 179:548-556.
5Novakoma-Jiresova A, van Luijk P, van Goor H, et al. Chan- ges in injury expression after graded volume irradiation of the rat lung[J]. Int J Radiat Oncol Biol Phys, 2006,66:572.
6Dang J, Li G, Lu XB,et al. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non- small-cell lung cancer treated with three-dimensional conformal radiotherapy[J]. J Cancer Res Clin Oncol, 2010,136 (8) : 1169- 1178.
7Wang S, Liao ZX, Wei X, et al. Analysis of clinical and dosimet- ric factors associated with treatment-related pneumonitis(THP) in patients with non-small-cell lung cancer(NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radio- therapy(3DCRT)[J]. Int J Radiat Oncol Biol Phys, 2006,66 :1399-1407.
8Shi AH, Zhu GY, et al. Analysis of clinical and dosimetric fac- tors associated with severe acute radiation pneumonitis in pa- tients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radio- therapy[J]. Radiation Oncology, 2010,5 : 35.
9Yom SS,Liao ZX,Liu HH,et al, Initial evaluation of treatment related pneumonitis in advaneed stage non small cell lung eaneer patients treated with concurrent chemotherapy and intensity modulated radiotherapy[J]. Int J Radiat Oncol Phys, 2007,68: 94-112.
10Schallenkamp JM, Miller RC, Brinkmann DH, Foote T, Garces YI:Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates[J]. Int J Radiat Oncol Biol Phys, 2007, 67:410-416.
2Tsujino K, Hirota S, Kotani Y, et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys, 2006,64: 1100-1105.
3Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC) : predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys, 2006, 65:1075-1086.
4Evans ES, Kocak Z, Zhou SM, et al. Does transforming growth factor-betal predict for radiation-induced pneumonitis in patients treated for lung cancer? Cytokine, 2006, 35(3-4) : 186-192.
5Rancati T, Ceresoli GL, Gagliardi G, et al. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol, 2003, 67 : 275-283.
6Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys, 2005, 63: 672-682.
7FLiao Z, Wei X, Liu H, et al. Analysis of Clinical and dosimetric factors associated with radiation pneumonitis (RP) in patients with non-small cell lung cancer( NSCLC ) treated with concurrent chemotherapy (ConChT) and three dimensional confonnal radiotherapy (3DCRT). Int J Radiat Oncol Biol Phys. 2006. 63 :S41-S41.
8Barthelemy-Brichant N, Bosquee L, Cataldo D,et al. Increased IL-6 and TGF-betal concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys, 2004, 58 : 758-767.
9Novakova-Jiresova A, van Gameren MM, Coppes RP, et al. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. Radiother Oncol, 2004, 71: 183- 189.
10Anscher MS, Kong FM, Andrews K, et al. Plasma transforming growth factor betal as a predictor of radiation pneumonitis. Int J Radiat Oneol Biol Phys, 1998, 41: 1029-1035.
5Madani I, De Ruyck K, Goeminne H, et al. Predicting risk of radiation induced lung injury [J]. J Thorac Oncol, 2007, 2: 864 874.
6Mao X, Wang T, Liu Y, et al. N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via re- storing HIF la/HO-1 signaling in diabetic rats [J]. PI.oS One, 2013, 8(7) :e68949.
7Sceneay J, Liu MC, Chen A, et al. The antioxidant N-acety|- cysteine prevents HIF-1 stabilization under hypoxia in vitro but does not affect tumorigenesis in multiple breast cancer models in vivo [J]. PLoSOne, 2013, 8(6):e66388.
8Demedts M, Behr J, Buhl R, etal. High-dose acetylcysteine in idiopathic pulmonary fibrosis [J]. N Engl J Med, 2005, 353 (21) : 2229-2242.
9Madani I, De - Ruyck K, Goeminne H, et al. Predicting risk of radia- tion- induced lung injury[ J]. J Thorac Oncol,2007,2(9 ) :864.
10Rancati T, Ceresoli G L, Gagliardi G, et al. Factors predicting radia- tion pneumonitis in lung cancer patients : a retrospective study [ J ]. Ra- diother Onco1,2003,67 (3) : 275.
